動脈插管市場機會、成長要素、產業趨勢分析及2026-2035年預測。

預計到 2025 年，全球動脈插管市場價值將達到 2,470 萬美元，並預計以 7.3% 的複合年成長率成長，到 2035 年達到 5,000 萬美元。

隨著先進心臟治療和挽救生命的緊急醫療干預在醫療保健系統中日益重要，動脈插管市場正穩步成長。心血管疾病發生率的上升以及生命維持技術的廣泛應用，持續推動對精準可靠的血管通路解決方案的需求。動脈插管在控制血流和維持複雜手術過程中的血流動力學穩定性方面發揮著至關重要的作用。插管設計方面的技術進步，例如材料改良、柔軟性增強和流體動態最佳化，進一步促進了其應用。此外，不斷擴大的保險覆蓋範圍和完善的報銷機制使先進的手術更容易獲得，從而支撐了整體市場成長。老年人口的成長以及生活方式相關風​​險因素的日益普遍，推動了外科手術和重症監護的需求。隨著醫療機構致力於改善患者預後和簡化手術流程，預計動脈插管市場在已開發地區和新興地區都將保持強勁的成長動能。

優惠的報銷政策和不斷擴大的重症監護手術保險覆蓋範圍，正顯著推動動脈插管市場的成長。許多地區的醫療系統正日益將高難度介入治療納入健保範圍，從而減輕病患和醫療機構的經濟負擔。這種財政支持正在加速需要動脈插管的手術的普及。隨著醫院持續投資於先進的外科手術能力和重症監護基礎設施，對高效能、高性能插管裝置的持續需求，進一步鞏固了市場需求和長期市場接受度。

預計到2025年，20-22 Fr規格的動脈插管銷售額將達到700萬美元，在動脈插管市場維持強勁地位。此規格的動脈插管因其符合成人解剖結構要求，且能夠在有效灌注的同時降低手術複雜性，並持續獲得市場認可。其均衡的設計確保了最佳血流，同時最大限度地降低了血管損傷和併發症的風險。隨著醫療專業人員日益重視病人安全、加快復健速度和改善手術效果，該規格的動脈插管與微創手術方法的契合度進一步推動了其市場應用。

預計到2025年，心肺體外迴圈手術市場規模將達到1,430萬美元，反映了其在複雜心血管手術中的關鍵作用。在需要暫時性心臟麻痹的手術中，動脈插管對於維持循環和氧氣供應仍然至關重要。插管設計的不斷進步提高了性能效率，使插入更加順暢，並更好地兼容不斷發展的外科技術。一定數量的高風險心血管手術推動了對動脈插管裝置的持續需求，凸顯了該細分市場對整體市場成長的強勁貢獻。

預計到2025年，北美動脈插管市佔率將達到42.5%，主要得益於該地區心血管疾病的高發生率和完善的醫療基礎設施。慢性病盛行率的上升和生活方式相關健康風險的增加，推動了該地區對先進心血管手術的需求持續成長。醫院和專科醫療中心在採用包括動脈插管在內的先進醫療技術以改善臨床療效方面發揮核心作用。預計在預測期內，對醫療創新持續投入，以及人們對早期診斷和治療意識的不斷提高，將進一步推動該地區的市場擴張。

目錄

第1章：調查方法

• 研究途徑
• 品質改進計劃
  • GMI人工智慧政策和資料完整性計劃
    • 資訊來源一致性協議
• 調查過程和可靠性評分
  • 調查過程的組成部分
  • 評分組成部分
• 數據收集
  • 主要來源部分列表
• 資料探勘資訊來源
  • 付費資訊來源
    • 區域資訊來源
• 基本估算和計算方法
  • 每種方法中基準年的計算
• 預測模型
  • 量化市場影響分析
    • 生長參數對預測的數學影響
• 關於調查透明度的補充信息
  • 資訊來源歸屬框架
  • 品質保證指標
  • 對信任的承諾

第2章執行摘要

第3章業界考察

• 生態系分析
• 影響產業的因素
  • 促進因素
    • 心血管疾病盛行率增加
    • 在重症監護環境中擴大呼吸和心臟支持設備的使用
    • 套管設計方面的進展
    • 心臟和緊急醫療程序的保險覆蓋範圍和承保範圍
  • 產業潛在風險與挑戰
    • 嚴格的監管要求
    • ECMO和心肺復甦術的複雜性。
  • 市場機遇
    • 兒童和新生兒專用插管的需求
• 成長潛力分析
• 監理情勢（基於初步調查）
  • 北美洲
  • 歐洲
  • 亞太地區
• 科技趨勢
  • 當前技術趨勢
  • 新興技術
• 未來市場趨勢（基於初步研究）
• 波特五力分析
• 人工智慧和生成式人工智慧對市場的影響
• PESTEL 分析

第4章 競爭情勢

• 介紹
• 企業市佔率分析
• 企業矩陣分析
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 主要進展
  • 併購
  • 夥伴關係與合作
  • 新產品發布
  • 業務拓展計劃

第5章 市場規模估算與預測（2022-2035年）

• 14～16 Fr
• 17～19 Fr
• 20～22 Fr
• 23～25 Fr
• 26～28 Fr
• 29～31 Fr
• 32～34 Fr
• 35-36 Fr

第6章 市場估計與預測：依應用領域分類，2022-2035年

• 心肺體外迴圈手術
• 體外膜氧合（ECMO）
• 其他用途

第7章 市場估計與預測：依最終用途分類，2022-2035年

• 醫院
• 門診手術中心
• 其他最終用戶

第8章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Andocor
• B. Braun
• Becton, Dickinson and Company
• Edward Lifesciences
• Freelife Medical
• Fresenius Medical Care
• Getinge
• LivaNova
• Medtronic
• Nipro Corporation
• Polymedicure
• Terumo Corporation
• Eurosets

The Global Arterial Cannula Market was valued at USD 24.7 million in 2025 and is estimated to grow at a CAGR of 7.3% to reach USD 50 million by 2035.

The arterial cannula market is witnessing steady expansion as healthcare systems increasingly prioritize advanced cardiac and critical care interventions. The growing incidence of cardiovascular conditions, combined with higher utilization of life-support technologies, continues to elevate demand for precise and reliable vascular access solutions. Arterial cannulas play a crucial role in enabling controlled blood flow and maintaining hemodynamic stability during complex procedures. Technological advancements in cannula design, including improved materials, enhanced flexibility, and optimized flow dynamics, are further strengthening adoption. In addition, broader insurance coverage and supportive reimbursement frameworks are making advanced procedures more accessible, which supports overall market growth. The rising elderly population, along with increasing prevalence of lifestyle-related risk factors, continues to intensify the need for surgical and critical care interventions. As healthcare providers focus on improving patient outcomes and procedural efficiency, the arterial cannula market is expected to maintain strong growth momentum across developed and emerging regions.

Favorable reimbursement structures and expanding insurance coverage for critical care procedures are significantly supporting the growth of the arterial cannula market. Healthcare systems across multiple regions are increasingly covering advanced interventions, which reduces cost pressures on both patients and medical institutions. This financial support encourages wider adoption of procedures requiring arterial cannulation. As hospitals continue to invest in advanced surgical capabilities and intensive care infrastructure, the consistent need for efficient and high-performance cannulation devices further strengthens market demand and long-term adoption trends.

The 20-22 Fr segment generated USD 7 million in 2025, maintaining a strong position within the arterial cannula market. This segment continues to gain preference due to its compatibility with adult anatomical requirements and its ability to deliver effective perfusion with reduced procedural complexity. Its balanced design supports optimal flow rates while minimizing risks associated with vascular damage and complications. The segment's alignment with minimally invasive surgical approaches further enhances its adoption, as healthcare providers increasingly prioritize patient safety, faster recovery, and improved procedural outcomes.

The cardiopulmonary bypass surgery segment reached USD 14.3 million in 2025, reflecting its critical importance in complex cardiac procedures. Arterial cannulas remain essential in maintaining circulation and oxygenation during surgical interventions that require temporary cardiac arrest. Continuous advancements in cannula design are improving performance efficiency, enabling smoother insertion and enhanced compatibility with evolving surgical techniques. The consistent volume of high-risk cardiac procedures ensures sustained demand for arterial cannulation devices, reinforcing this segment's strong contribution to overall market growth.

North America Arterial Cannula Market accounted for 42.5% share in 2025, supported by a high burden of cardiovascular conditions and strong healthcare infrastructure. The region continues to experience rising demand for advanced cardiac procedures, driven by the increasing prevalence of chronic conditions and lifestyle-related health risks. Hospitals and specialized care centers play a central role in adopting advanced medical technologies, including arterial cannulas, to improve clinical outcomes. Ongoing investments in healthcare innovation, coupled with growing awareness of early diagnosis and treatment, are expected to further strengthen regional market expansion over the forecast period.

Prominent players in the Global Arterial Cannula Market include Andocor, B. Braun, Becton, Dickinson and Company, Edward Lifesciences, Freelife Medical, Fresenius Medical Care, Getinge, LivaNova, Medtronic, Nipro Corporation, Polymedicure, Terumo Corporation, and Eurosets. Key strategies adopted by companies in the Global Arterial Cannula Market focus on continuous product innovation, strategic collaborations, and expansion of manufacturing capabilities to enhance their competitive positioning. Companies are investing in advanced materials and design improvements to deliver better flow performance, safety, and ease of use. Partnerships with healthcare providers and research institutions are helping accelerate product development and clinical validation. Market players are also strengthening their global footprint through mergers, acquisitions, and distribution network expansion. Additionally, emphasis on regulatory compliance, quality certifications, and customized product offerings tailored to specific clinical needs is enabling companies to build strong customer trust and long-term market presence.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Size trends
  • 2.2.2 Application trends
  • 2.2.3 End Use trends
  • 2.2.4 Regional trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of cardiovascular disorders
    • 3.2.1.2 Growing use of respiratory and cardiac support in critical care settings
    • 3.2.1.3 Advancements in cannula design
    • 3.2.1.4 Availability of reimbursements and coverage for cardiac and critical care procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulatory requirements
    • 3.2.2.2 Complexity associated with ECMO and cardiopulmonary procedures
  • 3.2.3 Market opportunities
    • 3.2.3.1 Demand for pediatric and neonatal specialized cannulas
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by primary research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends (Driven by primary research)
• 3.7 Porter's analysis
• 3.8 Impact of AI and generative AI on the market
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Size, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 14-16 Fr
• 5.3 17-19 Fr
• 5.4 20-22 Fr
• 5.5 23-25 Fr
• 5.6 26-28 Fr
• 5.7 29-31 Fr
• 5.8 32-34 Fr
• 5.9 35-36 Fr

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Cardiopulmonary bypass surgery
• 6.3 Extracorporeal membrane oxygenation
• 6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Andocor
• 9.2 B. Braun
• 9.3 Becton, Dickinson and Company
• 9.4 Edward Lifesciences
• 9.5 Freelife Medical
• 9.6 Fresenius Medical Care
• 9.7 Getinge
• 9.8 LivaNova
• 9.9 Medtronic
• 9.10 Nipro Corporation
• 9.11 Polymedicure
• 9.12 Terumo Corporation
• 9.13 Eurosets